ES8605534A1 - Procedimiento para producir un vehiculo de expresion de adn-replicable. - Google Patents

Procedimiento para producir un vehiculo de expresion de adn-replicable.

Info

Publication number
ES8605534A1
ES8605534A1 ES533485A ES533485A ES8605534A1 ES 8605534 A1 ES8605534 A1 ES 8605534A1 ES 533485 A ES533485 A ES 533485A ES 533485 A ES533485 A ES 533485A ES 8605534 A1 ES8605534 A1 ES 8605534A1
Authority
ES
Spain
Prior art keywords
production
cells transformed
sequences
processes involved
coding therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533485A
Other languages
English (en)
Other versions
ES533485A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8605534A1 publication Critical patent/ES8605534A1/es
Publication of ES533485A0 publication Critical patent/ES533485A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UN VEHICULO DE EXPRESION DE ADN REPLICABLE. CONSISTE EN COMBINAR UN PLASMIDO CON FRAGMENTO PROMOTOR Y SEÑAL DE PARTIDA DE TRASLACION CON UN FRAGMENTO A MEDIDA DE ADN ANIMAL QUE CONTIENE LA REGION CODIFICADORA DEL INTERFERON MADURO, MEDIANTE: 1) AISLAR ADN DE BOVINO, OBTENIENDO FRAGMENTOS ALEATORIOS DE 15-20 KILOBASES; 2) OBTENCION DE GENOMA DE UN FAGO LAMBDA CHARON 30 A; 3) INCUBACION DE ESTE GENOMA CON LOS FRAGMENTOS DE 15-20 KILOBASES CON POLINUCLEOTIDO LIGASA; 4) EMPAQUETAR EL GENOMA RECOMBINANTE EN PARTICULAS DE FAGO LAMBDA MADURO; 5) DONACION DE LOS FRAGMENTOS DE RESTRICCION DE LOS FAGOS RECOMBINANTES CON ENZIMAS DE RESTRICCION MULTIPLE EN UN PLASMIDO ADECUADO; 6) TRANSFORMACION DE UNA CEPA DE E.COLI CON EL PLASMIDO RECOMBINANTE Y EXPRESION DEL GEN CODIFICADOR DEL INTERFERAN. DE APLICACION EN LA OBTENCION DE INTERFERONAS QUE PUEDEN SER USADAS COMO AGENTES ANTIVIRALES.
ES533485A 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable. Expired ES8605534A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35529882A 1982-03-08 1982-03-08
US43812882A 1982-11-01 1982-11-01

Publications (2)

Publication Number Publication Date
ES8605534A1 true ES8605534A1 (es) 1986-04-01
ES533485A0 ES533485A0 (es) 1986-04-01

Family

ID=26998783

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520358A Granted ES520358A0 (es) 1982-03-08 1983-03-07 Procedimiento para producir polipeptido
ES533485A Expired ES8605534A1 (es) 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES520358A Granted ES520358A0 (es) 1982-03-08 1983-03-07 Procedimiento para producir polipeptido

Country Status (17)

Country Link
EP (1) EP0088622B1 (es)
JP (4) JP2633227B2 (es)
AT (1) ATE123813T1 (es)
AU (1) AU572447B2 (es)
CA (1) CA1339936C (es)
DD (1) DD207732A5 (es)
DE (2) DE3382789T2 (es)
DK (1) DK171790B1 (es)
ES (2) ES520358A0 (es)
FR (1) FR2530662B1 (es)
GB (1) GB2116566B (es)
IE (1) IE54592B1 (es)
IL (1) IL68059A (es)
NZ (1) NZ203493A (es)
PL (1) PL153902B1 (es)
PT (1) PT76353B (es)
YU (1) YU46722B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
GB2150573B (en) * 1983-02-24 1987-11-11 Inst Organicheskogo Sinteza Ak Leukocytic human interferon n and method to obtain it in bacterial cells
ZA843275B (en) * 1983-05-05 1984-12-24 Hoffmann La Roche Novel vectors for interferon expression
WO1985002200A1 (en) * 1983-11-14 1985-05-23 Chiron Corporation Interleukin-2 production using cloned genes for interleukin-2 and yeast alpha-factor
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3500961A1 (de) * 1985-01-14 1986-07-17 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Escherichia-coli-staemme, dna-teilsequenzen dieser staemme und herstellungsverfahren
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
ZA877924B (en) * 1985-12-04 1987-08-26 Immunex Corp Cloning,characterization,and expression of bovine gamma interferon
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
EP0271447B1 (de) * 1986-12-12 1993-03-10 Ciba-Geigy Ag Vorbeugende Massnahmen zur Verhinderung der "Komplexen Respiratorischen Erkrankung bei Rindern" durch Verabreichung von Interferon
DE3853523T2 (de) * 1987-12-29 1995-08-17 Toray Industries Synthetisches Plasmid, transformierte Zelle, Katzen-Interferon-Gen und Verfahren zur Herstellung von Katzen-Interferon.
AU3365989A (en) * 1988-03-23 1989-10-16 University Of Georgia Research Foundation, Inc., The Large-scale production of bovine leukocyte interferon
CA2019803C (en) * 1989-06-29 2000-04-25 Akira Yanai Feline interferon and process for production thereof
US5641656A (en) * 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
CA2501690C (en) * 2002-10-08 2012-04-03 Frank H. Gaertner Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants
BR0316324A (pt) * 2002-11-18 2005-09-27 Maxygen Inc Polipeptìdeos e conjugados de interferon-alfa
CN109206502B (zh) * 2018-09-26 2022-03-04 东北农业大学 一种猫干扰素ω及其制备方法和在抗病毒中的应用
CN112457391B (zh) * 2020-11-02 2022-10-04 天津大学 猪干扰素α、β、λ1在酿酒酵母中共分泌表达的方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
ES8308534A1 (es) * 1980-01-08 1983-09-01 Biogen Nv Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos.
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna

Also Published As

Publication number Publication date
YU46722B (sh) 1994-04-05
DE3308030C2 (de) 1996-03-28
ATE123813T1 (de) 1995-06-15
DD207732A5 (de) 1984-03-14
DK111183A (da) 1983-09-09
IL68059A0 (en) 1983-06-15
PT76353B (en) 1986-02-27
ES8500327A1 (es) 1984-11-01
PT76353A (en) 1983-04-01
DE3382789D1 (de) 1995-07-20
NZ203493A (en) 1987-08-31
JPS58224690A (ja) 1983-12-27
PL240926A1 (en) 1983-10-24
JPH06315385A (ja) 1994-11-15
DE3308030A1 (de) 1983-09-29
CA1339936C (en) 1998-06-30
JPH08187088A (ja) 1996-07-23
IL68059A (en) 1990-11-05
JP2721139B2 (ja) 1998-03-04
DK171790B1 (da) 1997-05-26
JP2633510B2 (ja) 1997-07-23
PL153902B1 (en) 1991-06-28
IE54592B1 (en) 1989-12-06
GB2116566B (en) 1985-11-27
JP2633227B2 (ja) 1997-07-23
FR2530662B1 (fr) 1985-11-15
FR2530662A1 (fr) 1984-01-27
EP0088622B1 (en) 1995-06-14
ES520358A0 (es) 1984-11-01
IE830471L (en) 1983-09-08
GB2116566A (en) 1983-09-28
YU55583A (en) 1986-04-30
AU1212283A (en) 1983-09-15
DE3382789T2 (de) 1995-12-14
GB8306225D0 (en) 1983-04-13
DK111183D0 (da) 1983-03-07
ES533485A0 (es) 1986-04-01
JPH0948799A (ja) 1997-02-18
EP0088622A2 (en) 1983-09-14
JP2677759B2 (ja) 1997-11-17
EP0088622A3 (en) 1984-08-01
AU572447B2 (en) 1988-05-12

Similar Documents

Publication Publication Date Title
ES8605534A1 (es) Procedimiento para producir un vehiculo de expresion de adn-replicable.
DE3377363D1 (en) Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
FI20000025A (fi) Menetelmä hemoglobiinin kaltainen yhdistelmäproteiinin valmistamiseksi
GR3021198T3 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
ATA392082A (de) Verfahren und vorrichtung zum handhaben von gegenstaenden mittels kontinuierlich bewegter arbeitsmittel
IE820069L (en) Recombinant dna encoding a polypeptide
ZA887773B (en) Interleukin-7
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
JPS6485098A (en) Glycoprotein and production thereof
EP0155832A3 (en) Stable proteins, methods for their construction, plasmids and other dna encoding them, cell cultures harboring such plasmids
EP0248642A3 (en) Interleukin-2 induced antineoplastic peptide

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050912